Highly protective antimalarial antibodies via precision library generation and yeast display screening
<jats:p>The monoclonal antibody CIS43 targets the Plasmodium falciparum circumsporozoite protein (PfCSP) and prevents malaria infection in humans for up to 9 mo following a single intravenous administration. To enhance the potency and clinical utility of CIS43, we used iterative site-saturatio...
Main Authors: | Banach, Bailey B, Tripathi, Prabhanshu, Da Silva Pereira, Lais, Gorman, Jason, Nguyen, Thuy Duong, Dillon, Marlon, Fahad, Ahmed S, Kiyuka, Patience K, Madan, Bharat, Wolfe, Jacy R, Bonilla, Brian, Flynn, Barbara, Francica, Joseph R, Hurlburt, Nicholas K, Kisalu, Neville K, Liu, Tracy, Ou, Li, Rawi, Reda, Schön, Arne, Shen, Chen-Hsiang, Teng, I-Ting, Zhang, Baoshan, Pancera, Marie, Idris, Azza H, Seder, Robert A, Kwong, Peter D, DeKosky, Brandon J |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Chemical Engineering |
Format: | Article |
Language: | English |
Published: |
Rockefeller University Press
2022
|
Online Access: | https://hdl.handle.net/1721.1/145918 |
Similar Items
-
Protective effects of combining monoclonal antibodies and vaccines against the Plasmodium falciparum circumsporozoite protein.
by: Lawrence T Wang, et al.
Published: (2021-12-01) -
Enhancing durability of CIS43 monoclonal antibody by Fc mutation or AAV delivery for malaria prevention
by: Neville K. Kisalu, et al.
Published: (2021-02-01) -
Novel antimalarial targets and the antimalarial pipeline
by: K. Chibale
Published: (2014-04-01) -
Mapping monoclonal anti-SARS-CoV-2 antibody repertoires against diverse coronavirus antigens
by: DeKosky, Brandon J.
Published: (2022) -
Design of Alphavirus Virus-Like Particles Presenting Circumsporozoite Junctional Epitopes That Elicit Protection against Malaria
by: Joseph R. Francica, et al.
Published: (2021-03-01)